GDC-0917
- Generic Name
- GDC-0917
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C29H36N6O4S
- CAS Number
- 1446182-94-0
- Unique Ingredient Identifier
- KWH46ZDG32
- Background
CUDC-427 has been used in trials studying the treatment of LYMPHOMA and Solid Cancers.
- Associated Conditions
- -
- Associated Therapies
- -
A Study Evaluating the Safety, Tolerability and Pharmacokinetics of GDC-0917 Administered to Patients With Refractory Solid Tumors or Lymphoma
- First Posted Date
- 2010-10-22
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 42
- Registration Number
- NCT01226277
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath